A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM
Clinical trial NCT03895697 · COMPLETED
Trial details
- NCT number
- NCT03895697
- Sponsor
- Zealand Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2019-07-30
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.